◆ 会议时间：2024年6月23-26日
◆ 会议地点：德国 莱比锡

◆ 会议简介：

2024年第45届欧洲细胞学大会(ECC2024)将于2024年6月23-26日在德国莱比锡举行，本次会议由欧洲细胞学联合会(EFCS)与匈牙利病理学会细胞病理学分会联合组织。

欧洲细胞学联合会(EFCS)成立于1969年，是代表整个欧洲细胞学界的联盟组织。其宗旨是：提供和促进医学与非医学(科学、技术)细胞学家的专业培训；就细胞学的训练、资格和实践的最低标准提出建议；鼓励对细胞学知识和经验的交流；促进有关细胞学的科学和组织项目，领域国际医学会议网译；在科学和组织层面帮助解决问题；支持细胞学应用，以获得补助；领域国际；就细胞学在疾病预防和诊断方面宣的作用向官方卫生机构提供建议；鼓励会员之间建立联系；定期组织大会、研讨会、专题讨论会、讲习班或培训课程。 未经本站许可禁止复制转载摘录本站任何内容-国际医学会议网(lingyuint.com)

45th European Congress of Cytology (ECC2024)

Date: 23-26 June 2024
Venue: Leipzig, Germany

Cytopathology The Clinical Interface

摘要征文投稿：

Call For Abstract

ABSTRACT SUBMISSION DEADLINE： 31 January 2024

点此提交摘要>>>Submit Abstract>>>

Abstract Authors

Abstract authors include four different categories:

1. First Author: the first author who submitted the abstract and to whom all correspondence from ECC2024 will be senti s the Presenting Author.
2. Co-Authors: each co-Author in each abstract’s author string.
   In order to have correct information in the indices and the website of ECC2024, author names in multiple abstracts have to be consistent. For example: Robert Grant belongs to the author string of more abstracts, the name R. Grant must be written this way in all abstracts and not in different ways, such as Rob Grant, Grant Rob…
3. Affiliations: short affiliation is required for each author or group of authors, including Department, Institution, City and Country. Please do not insert authors’ names and affiliations in the .doc document you are required to upload.

The indication of the preferable presentation type (Oral Communication / Poster) is mandatory.

The final allocation of the abstract will be decided by the Abstract Selection Committee.

Abstract must be submitted electronically only via the Abstract Submission Form. An acknowledgement of the receipt of the abstract will be sent automatically by e-mail to the presenting author upon the on-line submission.

Abstract text

In order to set a common standard for the abstracts publication, authors are requested to organize the abstract as follows:

1. Introduction – statement of the hypothesis or research question.
2. Methods – an explanation of the study design and experimental methods used.
3. Results – A concise summary of the major findings of the experiment or study. Sufficient data must be provided to permit evaluation by the reviewers and public reading.
4. Conclusions – Summary of the overall findings and the importance of the study.

When preparing the text, please remember

• Use generic drug names.
• Do not begin sentences with numerals.
• Standard abbreviations may be used without definition. Non-standard abbreviations (kept to a minimum) must be placed in parenthesis after the first use of the word or phrase abbreviated.
• Do not include references, credit or grant support.
• Do not include the names or personal information of any patient participating in the study or trial.

Abstract Format

The text should contain no more than 180 words, figures or tables excluded. A maximum of 2 figures/tables/graphics is acceptable.

Typeface “Times New Roman”, Font size 12.

In order to avoid blank lines, please single-space all typing. Be sure that any text included in graphics, if any, will be legible at the defined size.

Abstract Revisions

Carefully proofread the abstract, make any necessary revisions before the submission deadline date and be sure that the English level is appropriate for a scientific abstract. Each abstract can only be submitted once. The same abstract cannot be submitted for consideration in different categories.

Acceptance

Notification of Acceptance/Non-acceptance will be e-mailed by April 30th 2024.

Registration of Abstract presenters

Abstract presenters must register and pay the registration fee within January 31st 2024.
The registration will ensure the presentation of the abstract during the congress.
Expenses are under the presenter’s responsibility. Only the first author listed is considered the presenter. If registration is not accomplished within the scheduled deadline the abstract will not be rewieved. Please make sure you inform the Organizing Secretariat of any changes you would like to make.

INVITATION

Dear colleagues,

it’s our honour and pleasure to welcome you to Leipzig for the 45th European Congress of Cytology. In collaboration with colleagues from several other European Societies we’ve devised a program covering a wide scope of topics, including “classical” subjects like cervical cancer screening, but also rather new topics like artificial intelligence and it’s role in cytology.

The motto of the congress “Cytopathology: The Clinical Interface” points to some specific features of cytological practice in Germany. Many members of the German Society of Cytology are clinicians and are bridging every day the gap between clinical practice and diagnostic work at the microscope. More than one session will focus on this close interaction, including lectures and discussion, but also live demonstrations in collaboration with our colleagues in clinical departments.

Leipzig is a city in Saxonia in the eastern part of Germany. Leipzig has been a center for trade since old times – the Leipzig trade fair dates back to 1190 – and now is an economic center of the region. Leipzig has a long tradition in music and art and in book publishing. Leipzig is home to one of the oldest universities in Germany and now a center of science.

Leipzig has hosted the ECC before: In the dynamic times of the “Wende” in September 1990 Prof. Dr. Peter Leonhardt, who died a few months ago, organized the 18th ECC in the German Democratic Republic.

So, we invite you to come to Leipzig in June 2024: Join the meeting, present your research and meet colleagues and friends.
We look forward to see you in Leipzig!

For the German Society of Cytology,

Dr. med Marianne Engels, FIAC

Congress President

注册费：

◆ 参会对象：细胞学家，研究人员、临床医生以及该从事该领域研究的专家、科研人员、医药企业代表等等。